Filing Details

Accession Number:
0001140361-14-043442
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-11-25 17:04:29
Reporting Period:
2014-11-25
Filing Date:
2014-11-25
Accepted Time:
2014-11-25 17:04:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1367644 Emergent Biosolutions Inc. EBS Pharmaceutical Preparations (2834) 141902018
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1380184 Zsolt Harsanyi 2273 Research Blvd
Suite 400
Rockville MD 20850
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2014-11-25 8,000 $11.67 27,100 No 4 M Direct
Common Stock Disposition 2014-11-25 8,000 $24.82 19,100 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option Disposition 2014-11-25 8,000 $0.00 8,000 $11.67
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
13,600 2010-05-21 2019-05-21 No 4 M Direct
Footnotes
  1. Consists of options granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan.
  2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.75 to $24.94, inclusive.
  3. The option vested in three equal installments on May 21, 2010, 2011 and 2012.